55 related articles for article (PubMed ID: 30290280)
1. Synthesis, molecular docking and inhibition studies of novel 3-N-aryl substituted-2-heteroarylchromones targeting microtubule affinity regulating kinase 4 inhibitors.
Parveen I; Khan P; Ali S; Hassan MI; Ahmed N
Eur J Med Chem; 2018 Nov; 159():166-177. PubMed ID: 30290280
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, bioactivity assessment, molecular docking and ADMET studies of new chromone congeners exhibiting potent anticancer activity.
Abo-Salem HM; El Souda SSM; Shafey HI; Zoheir KMA; Ahmed KM; Mahmoud K; Mahrous KF; Fawzy NM
Sci Rep; 2024 Apr; 14(1):9636. PubMed ID: 38671055
[TBL] [Abstract][Full Text] [Related]
3. MAP/Microtubule Affinity Regulating Kinase 4 Inhibitory Potential of Irisin: A New Therapeutic Strategy to Combat Cancer and Alzheimer's Disease.
Waseem R; Anwar S; Khan S; Shamsi A; Hassan MI; Anjum F; Shafie A; Islam A; Yadav DK
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681645
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of novel JNK inhibitors targeting liver pyruvate kinase for the treatment of non-alcoholic fatty liver disease and hepatocellular carcinoma.
Iqbal S; Sebhaoui J; Ashraf S; Ozcan M; Kim W; Belmen B; Yeşilyurt G; Hanashalshahaby E; Zhang C; Uhlen M; Boren J; Turkez H; Mardinoglu A
Bioorg Chem; 2024 Jun; 147():107425. PubMed ID: 38714117
[TBL] [Abstract][Full Text] [Related]
5. Chemical Constituent Profiling of
Abdelhameed RFA; Habib ES; Ibrahim AK; Yamada K; Abdel-Kader MS; Ahmed SA; Ibrahim AK; Badr JM; Nafie MS
Molecules; 2021 Feb; 26(4):. PubMed ID: 33578916
[TBL] [Abstract][Full Text] [Related]
6. Harnessing memantine in Alzheimer's disease therapy through inhibition of microtubule affinity-regulating kinase: Mechanistic insights.
Anwar S; Choudhury A; Hussain A; AlAjmi MF; Hassan MI; Islam A
Int J Biol Macromol; 2024 Mar; 262(Pt 2):130090. PubMed ID: 38342269
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, molecular docking studies and biological evaluation of N-(4-oxo-2-(trifluoromethyl)-4H-chromen-7-yl) benzamides as potential antioxidant, and anticancer agents.
Jorepalli S; Adikay S; Chinthaparthi RR; Gangireddy CSR; Koduru JR; Karri RR
Sci Rep; 2024 Apr; 14(1):9866. PubMed ID: 38684797
[TBL] [Abstract][Full Text] [Related]
8. Biological Evaluation of 3-Benzylidenechromanones and Their Spiropyrazolines-Based Analogues.
Adamus-Grabicka AA; Markowicz-Piasecka M; Cieślak M; Królewska-Golińska K; Hikisz P; Kusz J; Małecka M; Budzisz E
Molecules; 2020 Apr; 25(7):. PubMed ID: 32244705
[TBL] [Abstract][Full Text] [Related]
9. One-pot synthesis, structural investigation, antitumor activity and molecular docking approach of two decavanadate compounds.
Dridi R; Abdelkafi-Koubaa Z; Srairi-Abid N; Socha B; Zid MF
J Inorg Biochem; 2024 Jun; 255():112533. PubMed ID: 38547784
[TBL] [Abstract][Full Text] [Related]
10. Ropinirole reverses the effects of neuroinflammation, and cellular demise by downregulating the MARK4-NFκβ signaling system in Alzheimer's disease.
Neha ; Anwar S; Pinky ; Hassan MI; Parvez S
Int J Biol Macromol; 2024 May; 271(Pt 1):132425. PubMed ID: 38759860
[TBL] [Abstract][Full Text] [Related]
11. Design and Development of Novel Urea, Sulfonyltriurea, and Sulfonamide Derivatives as Potential Inhibitors of
Roy S; Mahapatra AD; Mohammad T; Gupta P; Alajmi MF; Hussain A; Rehman MT; Datta B; Hassan MI
Pharmaceuticals (Basel); 2020 Jun; 13(6):. PubMed ID: 32526899
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Hordenine as a Potential Inhibitor of Pyruvate Dehydrogenase Kinase 3: Implication in Lung Cancer Therapy.
Anwar S; Mohammad T; Shamsi A; Queen A; Parveen S; Luqman S; Hasan GM; Alamry KA; Azum N; Asiri AM; Hassan MI
Biomedicines; 2020 May; 8(5):. PubMed ID: 32422877
[TBL] [Abstract][Full Text] [Related]
13. Structural and biochemical investigation of MARK4 inhibitory potential of cholic acid: Towards therapeutic implications in neurodegenerative diseases.
Anwar S; Shamsi A; Kar RK; Queen A; Islam A; Ahmad F; Hassan MI
Int J Biol Macromol; 2020 Oct; 161():596-604. PubMed ID: 32535203
[TBL] [Abstract][Full Text] [Related]
14. Design and Development of Small-Molecule Arylaldoxime/5-Nitroimidazole Hybrids as Potent Inhibitors of MARK4: A Promising Approach for Target-Based Cancer Therapy.
Peerzada MN; Khan P; Khan NS; Avecilla F; Siddiqui SM; Hassan MI; Azam A
ACS Omega; 2020 Sep; 5(36):22759-22771. PubMed ID: 32954123
[TBL] [Abstract][Full Text] [Related]
15. Identification of α-Mangostin as a Potential Inhibitor of Microtubule Affinity Regulating Kinase 4.
Khan P; Queen A; Mohammad T; Smita ; Khan NS; Hafeez ZB; Hassan MI; Ali S
J Nat Prod; 2019 Aug; 82(8):2252-2261. PubMed ID: 31343173
[TBL] [Abstract][Full Text] [Related]
16. Probing the Inhibition of Microtubule Affinity Regulating Kinase 4 by N-Substituted Acridones.
Voura M; Khan P; Thysiadis S; Katsamakas S; Queen A; Hasan GM; Ali S; Sarli V; Hassan MI
Sci Rep; 2019 Feb; 9(1):1676. PubMed ID: 30737440
[TBL] [Abstract][Full Text] [Related]
17. Design and development of Isatin-triazole hydrazones as potential inhibitors of microtubule affinity-regulating kinase 4 for the therapeutic management of cell proliferation and metastasis.
Aneja B; Khan NS; Khan P; Queen A; Hussain A; Rehman MT; Alajmi MF; El-Seedi HR; Ali S; Hassan MI; Abid M
Eur J Med Chem; 2019 Feb; 163():840-852. PubMed ID: 30579124
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Coumarin as Microtubule Affinity-Regulating Kinase 4 Inhibitor That Sensitize Hepatocellular Carcinoma to Paclitaxel.
Shen X; Liu X; Wan S; Fan X; He H; Wei R; Pu W; Peng Y; Wang C
Front Chem; 2019; 7():366. PubMed ID: 31179271
[TBL] [Abstract][Full Text] [Related]
19. SET8 mitigates hepatic ischemia/reperfusion injury in mice by suppressing MARK4/NLRP3 inflammasome pathway.
Luo Y; Huang Z; Mou T; Pu J; Li T; Li Z; Yang H; Yan P; Wu Z; Wu Q
Life Sci; 2021 May; 273():119286. PubMed ID: 33662429
[TBL] [Abstract][Full Text] [Related]
20. In Vitro and In Silico Analysis of the Bindings between Legacy and Novel Per- and Polyfluoroalkyl Substances and Human Serum Albumin.
Wu Y; Bao J; Liu Y; Wang X; Lu X; Wang K
Toxics; 2024 Jan; 12(1):. PubMed ID: 38251003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
